p27 Monoclonal Antibody

This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).

Introducing the P27 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunology. This meticulously crafted antibody is the result of years of scientific research and development, aimed at providing a highly specific and efficient tool for various applications in the medical and research communities.

The P27 Monoclonal Antibody boasts an exceptional level of purity and specificity, ensuring unparalleled accuracy and reliability in its binding capabilities. Its unique composition enables it to selectively target and bind to a specific antigen, facilitating the identification and analysis of various cellular components with utmost precision.

This groundbreaking antibody exhibits remarkable versatility, making it an invaluable asset in a wide range of applications. From diagnostic assays to therapeutic interventions, the P27 Monoclonal Antibody offers an array of possibilities for researchers and clinicians alike. Its exceptional performance in immunohistochemistry, flow cytometry, and western blotting techniques further enhances its utility and applicability in diverse experimental settings.

Furthermore, the P27 Monoclonal Antibody is manufactured using state-of-the-art techniques and adheres to the highest quality standards. Rigorous quality control measures ensure batch-to-batch consistency, guaranteeing reproducibility and reliability in experimental outcomes. Its long shelf life and stability further contribute to its appeal as a dependable reagent for long-term studies and experiments.

In summary, the P27 Monoclonal Antibody represents a groundbreaking advancement in the field of immunology. Its exceptional purity, specificity, and versatility make it an indispensable tool for researchers and clinicians seeking to unravel the complexities of cellular biology. With its unrivaled performance and adherence to stringent quality standards, the P27 Monoclonal Antibody sets a new benchmark for excellence in the realm of biotechnological products.